title: Authors' response.
authors.affiliation: *Jerusalem, Israel †Kansas City, MO.
authors.forename: Dan
authors.initials: D
authors.lastname: Turner
authors.forename: Craig
authors.initials: C
authors.lastname: Friesen
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D004760:Enterocolitis / Q000188:drug therapy*; D004802:Eosinophilia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha